Table 4.
PC + CSH, g/kg of diet | Dose trends (P-values) | |||||||
---|---|---|---|---|---|---|---|---|
Items | NC | PC | 100 | 150 | 200 | SEM | Linear | Quadratic |
Oxidative parameters | ||||||||
DAO, U/liter | 0.70d | 2.21a | 1.08b | 0.99bc | 0.97c | 0.026 | 0.002 | 0.226 |
MDA, nmol/liter | 2.78c | 5.02a | 4.21b | 4.08b | 3.98b | 0.058 | 0.006 | 0.760 |
PCO, nmol/g | 22.91d | 37.57a | 31.33b | 29.43bc | 28.01c | 0.560 | 0.001 | 0.739 |
Inflammatory factors | ||||||||
IL-1β, ng/liter | 42.54d | 133.6a | 98.76b | 82.60c | 75.46c | 2.300 | <0.001 | 0.077 |
IL-6, ng/liter | 58.68c | 154.5a | 110.8b | 111.7b | 103.2b | 2.513 | 0.083 | 0.204 |
TNF-α, ng/liter | 34.84d | 125.8a | 80.10b | 80.29b | 68.27c | 1.647 | <0.001 | 0.001 |
a–d Means within a row with no common superscripts are significantly different (P < 0.05).
CSH, cysteamine hydrochloride; DAO, diamine oxidase; IL-1β, interleukin-1β; IL-6, interleukin-6; MDA, malondialdehyde; NC, negative control, without C. perfringens challenge; PC, positive control, challenged with C. perfringens; PCO, protein carbonyl; TNF-α, tumor necrosis factor-α.